Cools’ laboratory used targeted single-cell sequencing of total BM cells and CD34+CD38− multipotent progenitor cells to reveal the genetic basis of disease initiation in T-cell ALL (T-ALL). This evidence concerns the gene CD34 and acute lymphoblastic leukemia.